NO143534C - Analogifremgangsmaate for fremstilling av terapeutisk virksomme derivater av oxatiino(1,4)(2,3-c)pyrrol. - Google Patents

Analogifremgangsmaate for fremstilling av terapeutisk virksomme derivater av oxatiino(1,4)(2,3-c)pyrrol.

Info

Publication number
NO143534C
NO143534C NO753712A NO753712A NO143534C NO 143534 C NO143534 C NO 143534C NO 753712 A NO753712 A NO 753712A NO 753712 A NO753712 A NO 753712A NO 143534 C NO143534 C NO 143534C
Authority
NO
Norway
Prior art keywords
oxatiino
pyrrol
preparation
therapeutically effective
analogy procedure
Prior art date
Application number
NO753712A
Other languages
English (en)
Other versions
NO753712L (no
NO143534B (no
Inventor
Claude Cotrel
Claude Jeanmart
Michel Barreau
Original Assignee
Rhone Poulenc Ind
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rhone Poulenc Ind filed Critical Rhone Poulenc Ind
Publication of NO753712L publication Critical patent/NO753712L/no
Publication of NO143534B publication Critical patent/NO143534B/no
Publication of NO143534C publication Critical patent/NO143534C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/38—Nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D497/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having oxygen and sulfur atoms as the only ring hetero atoms
    • C07D497/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having oxygen and sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D497/04—Ortho-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Anesthesiology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Pyrrole Compounds (AREA)
NO753712A 1974-11-07 1975-11-06 Analogifremgangsmaate for fremstilling av terapeutisk virksomme derivater av oxatiino(1,4)(2,3-c)pyrrol. NO143534C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7436962A FR2290208A1 (fr) 1974-11-07 1974-11-07 Nouveaux derives de l'oxathiinno(1,4)(2,3-c)pyrrole, leur preparation et les compositions qui les contiennent

Publications (3)

Publication Number Publication Date
NO753712L NO753712L (no) 1976-05-10
NO143534B NO143534B (no) 1980-11-24
NO143534C true NO143534C (no) 1981-03-04

Family

ID=9144747

Family Applications (1)

Application Number Title Priority Date Filing Date
NO753712A NO143534C (no) 1974-11-07 1975-11-06 Analogifremgangsmaate for fremstilling av terapeutisk virksomme derivater av oxatiino(1,4)(2,3-c)pyrrol.

Country Status (28)

Country Link
US (1) US4021554A (no)
JP (2) JPS6029716B2 (no)
AR (2) AR214045A1 (no)
AT (1) AT342603B (no)
AU (1) AU503381B2 (no)
BE (1) BE835324A (no)
CA (1) CA1054599A (no)
CH (2) CH608238A5 (no)
CS (1) CS191285B2 (no)
DD (1) DD122541A5 (no)
DE (1) DE2550163C2 (no)
DK (1) DK499175A (no)
ES (2) ES442441A1 (no)
FI (1) FI59251C (no)
FR (1) FR2290208A1 (no)
GB (1) GB1466829A (no)
HU (1) HU170500B (no)
IE (1) IE42030B1 (no)
IL (1) IL48422A (no)
LU (1) LU73737A1 (no)
NL (1) NL7512731A (no)
NO (1) NO143534C (no)
OA (1) OA05141A (no)
PH (1) PH14755A (no)
SE (1) SE419222B (no)
SU (2) SU576949A3 (no)
YU (2) YU281175A (no)
ZA (1) ZA756953B (no)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1072557A (fr) * 1976-02-20 1980-02-26 Rhone-Poulenc Industries Derives du dithiepinno (1,4)(2,3-c) pyrrole, leur preparation et les compositions qui les contiennent
FR2525605A1 (fr) * 1982-04-22 1983-10-28 Rhone Poulenc Sante Nouveaux derives du dithiinno (1,4) (2,3-c) pyrrole, leur preparation et les medicaments qui les contiennent
FR2607504B1 (fr) * 1986-12-02 1989-01-27 Rhone Poulenc Sante Nouveaux derives de l'isoindolinone, leur preparation et les compositions pharmaceutiques qui les contiennent
DK2164501T3 (en) * 2007-05-31 2016-05-30 Paradigm Biopharmaceuticals Ltd Sulfated xylans for the treatment or prophylaxis of respiratory diseases

Also Published As

Publication number Publication date
FI59251C (fi) 1981-07-10
CH608808A5 (no) 1979-01-31
FR2290208B1 (no) 1978-07-28
CH608238A5 (no) 1978-12-29
AT342603B (de) 1978-04-10
ES442441A1 (es) 1977-04-01
US4021554A (en) 1977-05-03
BE835324A (fr) 1976-05-06
IE42030L (en) 1976-05-07
OA05141A (fr) 1981-01-31
JPS5170792A (en) 1976-06-18
SU576949A3 (ru) 1977-10-15
DK499175A (da) 1976-05-08
CA1054599A (fr) 1979-05-15
SU615860A3 (ru) 1978-07-15
JPS60222484A (ja) 1985-11-07
IL48422A0 (en) 1976-01-30
IL48422A (en) 1979-03-12
AU503381B2 (en) 1979-08-30
DE2550163C2 (de) 1984-11-22
HU170500B (no) 1977-06-28
GB1466829A (en) 1977-03-09
ATA848575A (de) 1977-08-15
JPS6111954B2 (no) 1986-04-05
AU8633275A (en) 1977-05-12
NO753712L (no) 1976-05-10
FR2290208A1 (fr) 1976-06-04
ZA756953B (en) 1976-10-27
JPS6029716B2 (ja) 1985-07-12
NL7512731A (nl) 1976-05-11
SE7512476L (sv) 1976-05-10
ES442442A1 (es) 1977-07-01
IE42030B1 (en) 1980-05-21
LU73737A1 (no) 1976-09-06
DE2550163A1 (de) 1976-05-20
AR214400A1 (es) 1979-06-15
YU108082A (en) 1982-08-31
SE419222B (sv) 1981-07-20
PH14755A (en) 1981-11-20
YU281175A (en) 1982-08-31
FI753126A (no) 1976-05-08
DD122541A5 (no) 1976-10-12
FI59251B (fi) 1981-03-31
CS191285B2 (en) 1979-06-29
NO143534B (no) 1980-11-24
AR214045A1 (es) 1979-04-30

Similar Documents

Publication Publication Date Title
NO144850C (no) Analogifremgangsmaate til fremstilling av immunpotenserende glukosaminderivater.
NO145433C (no) Fremgangsmaate til fremstilling av 1,3-butadien.
SE7604475L (sv) Forfarande for framstellning av 1,1,1-triaryl-alkylaminer
NO151365C (no) Fremgangsmaate for fremstilling av 4-halogen-dihydropyran-derivater.
SE7504842L (sv) Forfarande for framstellning av adeninderivat..
SE419983B (sv) Forfarande for framstellning av finkornig, fast cyanurklorid
SE409864B (sv) Forfarande for framstellning av 4-imino-1,3-diazabicyklo(3.1.0)hexan-2-on
SE428015B (sv) Forfarande for framstellning av 3.4-dihydrokarbostyrilderivat
SE428922B (sv) Forfarande for framstellning av 13, 14-dihydro-11-dioxi-prostaglandiner
SE399895B (sv) Forfarande for framstellning av s-triazolo(3,4-b)benstiazoler
NO143534C (no) Analogifremgangsmaate for fremstilling av terapeutisk virksomme derivater av oxatiino(1,4)(2,3-c)pyrrol.
SE426067B (sv) Forfarande for framstellning av 9-hydroxi-7,8,9,10-tetrahydro-6h-dibenso (b,d) pyraner och -pyranoner
DK135167B (da) Analogifremgangsmåde til fremstilling af 7,7'-ditheophyllinderivater.
SE7600847L (sv) Nytt forfarande for framstellning av 8-bromtienotriazolo-1,4-diazepiner
AR211854A1 (es) Procedimiento de preparacion de derivados polisustituidos de 10-piperazinodibenzo(b,f)tiepina
NO811390L (no) Fremgangsmaate til fremstilling av 6,11-dihydro-11-oksodibenz(b,e)-oksepinalkansyrer
SE7512422L (sv) Forfarande for framstellning av 1,2,3,4-tetrahydroisokinoliner
SE7608453L (sv) Forfarande for framstellning av 1,2,3,4-tetrahydroisokinoliner
NO143626C (no) Fremgangsmaate til fremstilling av 2-alkyl-5-nitroimidazolderivater.
SE7507922L (sv) Forfarande for framstellning av 2(lh)-kinazolinonderivat.
AR210905A1 (es) Procedimiento de preparacion de 2,4-diamino-5-bencil-pirimidinas
NO145882C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive 2,3,8,12b-tetrahydro-1h-3a,8-methandibenzo(3,4:6,7)-cyclo-hepta(1,2-c)pyrrol-derivater
DK137274B (da) Analogifremgangsmåde til fremstilling af 2,3-dihydrobenzofuranon-2-derivater.
NO813820L (no) Fremgangsmaate ved fremstilling av 7-methoxy-cefalosporin-derivater.
SE7505066L (sv) Forfarande for framstellning av cefalsporinderivat.